248 related articles for article (PubMed ID: 17644403)
1. A comprehensive systematic review of testicular germ cell tumor surveillance.
Groll RJ; Warde P; Jewett MA
Crit Rev Oncol Hematol; 2007 Dec; 64(3):182-97. PubMed ID: 17644403
[TBL] [Abstract][Full Text] [Related]
2. Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.
John A; Baumgart A; Worst T; Heinzelbecker J
Urol Int; 2018; 100(3):279-287. PubMed ID: 29514158
[TBL] [Abstract][Full Text] [Related]
3. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
4. [Testicular tumors--a current review].
Buse S; Lurati G; Schmid HP
Praxis (Bern 1994); 2003 Nov; 92(47):1989-97. PubMed ID: 14669500
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
Kunath F; Spek A; Jensen K; Zengerling F; Schmidt S
Syst Rev; 2015 Dec; 4():182. PubMed ID: 26684760
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of urological malignancy: the testes.
Wilkins M; Horwich A
Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
8. [Metachronous testicular seminoma with an interval of 14 years from the first nonseminomatous testicular tumor: a case report].
Kawasaki M; Satoh Y; Nakashima K; Nishimura K; Kaneko A; Udoh K; Fujiyama C; Uozumi J
Nihon Hinyokika Gakkai Zasshi; 2009 Jan; 100(1):16-21. PubMed ID: 19198225
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and therapy of testicular tumors].
Albers P
Urologe A; 2002 Jul; 41(4):374-85; quiz 386-7. PubMed ID: 12214458
[No Abstract] [Full Text] [Related]
10. Long term outcome and cost in the management of stage I testicular seminoma.
Warde P; Gospodarowicz MK; Panzarella T; Chow E; Murphy T; Catton CN; Sturgeon JF; Moore M; Milosevic M; Jewett MA
Can J Urol; 2000 Apr; 7(2):967-72; discussion 973.. PubMed ID: 11119439
[TBL] [Abstract][Full Text] [Related]
11. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
[TBL] [Abstract][Full Text] [Related]
12. Clinical stage I synchronous bilateral testicular germ cell tumor with different histopathology: a case report.
Salazar-Mejía CE; Wimer-Castillo BO; García-Arellano G; Garza-Guajardo R; Vidal-Gutiérrez O; Zayas-Villanueva OA; Vera-Badillo FE
Pan Afr Med J; 2020; 37():319. PubMed ID: 33680279
[TBL] [Abstract][Full Text] [Related]
13. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases].
Berger N; Droz JP
Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737
[No Abstract] [Full Text] [Related]
14. [Testicular Cancer: Diagnostics, Therapy and Follow Up].
Kälin M; Mauti L; Pless M
Praxis (Bern 1994); 2016 May; 105(11):643-8. PubMed ID: 27223417
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of testicular germ cell tumors relapse].
Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
[TBL] [Abstract][Full Text] [Related]
16. Management of Clinical Stage I Testicular Cancer: How Should We Define Success?
Pagliaro LC; Tannir NM; Tu SM; Logothetis CJ
J Clin Oncol; 2015 Jul; 33(20):2321-2. PubMed ID: 26033805
[No Abstract] [Full Text] [Related]
17. Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.
Bobrowski A; Anson-Cartwright L; Kuhathaas K; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Hamilton RJ
J Urol; 2022 Dec; 208(6):1250-1258. PubMed ID: 35997696
[TBL] [Abstract][Full Text] [Related]
18. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
19. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Treatment of Testicular Cancer: A Clinician's Perspective.
Bernard B; Sweeney CJ
Surg Pathol Clin; 2015 Dec; 8(4):717-23. PubMed ID: 26612223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
